Abstract
Implantable cardioverter defibrillator (ICD) has been accepted as primary therapy for patients with life-threatening ventricular tachyarrhythmias. ICDs with dual chamber sensing and pacing capabilities are now available for better discrimination between supraventricular and ventricular arrhythmias.
Recommended Citation
KATHERINE FAN, KATHY LEE, ELAINE CHAU, ALEX YIP, Implantable Cardioverter Defibrillator: Clinical Performance of Dual Chamber versus Single Chamber Devices Journal of the Hong Kong College of Cardiology 2022;7(2):96-103 https://doi.org/10.55503/2790-6744.1387
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
COinS